Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Cellulitis from Bug Bites

Microbiology and Treatment Principles

  • Cellulitis is most commonly caused by streptococci and Staphylococcus aureus, with bug bites potentially introducing normal skin flora, including S. aureus, as common pathogens 3, 2
  • The Infectious Diseases Society of America recommends beta-lactam antibiotics as first-line therapy for typical non-purulent cellulitis, targeting streptococci effectively 2, 6
  • A 5-day course of antimicrobial therapy can be as effective as a 10-day course if clinical improvement occurs, according to the Infectious Diseases Society of America 2, 7

Antibiotic Selection

  • Doxycycline is recommended for empiric coverage of CA-MRSA, for outpatients with purulent cellulitis, and when there's concern for both streptococcal and staphylococcal infection, including MRSA, as suggested by the Infectious Diseases Society of America 1, 2
  • Combination therapy with doxycycline and a beta-lactam (e.g., amoxicillin, cephalexin) is an option for coverage of both beta-hemolytic streptococci and CA-MRSA, as per the Infectious Diseases Society of America guidelines 1, 2

Special Considerations

  • Bug bites represent a form of penetrating trauma, increasing the risk of S. aureus infection, including MRSA, as noted by the Infectious Diseases Society of America 2, 5
  • In cases of cellulitis associated with water exposure after a bug bite, consider coverage for water-associated pathogens (Aeromonas, Vibrio) with doxycycline, as recommended by the Infectious Diseases Society of America 5

Duration and Adjunctive Therapy

  • The Infectious Diseases Society of America recommends 5-10 days of therapy for uncomplicated cellulitis, with duration based on clinical response 1, 2
  • Elevation of the affected area is an important adjunct to antibiotic therapy to promote drainage of edema and inflammatory substances, as suggested by the Infectious Diseases Society of America 5
  • Consider local resistance patterns when selecting empiric therapy, as advised by the European Society of Clinical Microbiology and Infectious Diseases 3, 8